Indoco Remedies Limited
NSE: INDOCO BSE: INDOCO
NSE
326.45
-0.45 (-0.14%)
Prev Close
326.9
Open Price
324.55
Volume
174,646
Today Low / High
324.55 / 331
52 WK Low / High
190 / 387.55
Range
310 - 343
BSE
325.90
-1.15 (-0.35%)
Prev Close
327.05
Open Price
326.25
Volume
4,865
Today Low / High
324.8 / 331
52 WK Low / High
190 / 385.5
Range
310 - 342
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 326.45 (target range: 310 - 343), reflecting a change of -0.45 (-0.13766%). On the BSE, it is listed at 325.9 (target range: 310 - 342), showing a change of -1.15 (-0.35163%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
11 Jul
324.55
0.59%
10 Jul
330.30
-1.03%
09 Jul
321.90
3.39%
08 Jul
329.95
-1.45%
07 Jul
339.00
-2.79%
04 Jul
342.20
-1.04%
03 Jul
323.10
4.86%
02 Jul
311.55
3.34%
01 Jul
317.60
-1.42%
30 Jun
300.50
5.69%
27 Jun
295.10
2.24%
26 Jun
291.90
1.10%
25 Jun
287.00
1.71%
24 Jun
282.30
0.94%
23 Jun
281.10
1.17%
20 Jun
279.50
1.99%
19 Jun
284.85
-1.16%
18 Jun
286.00
-1.12%
17 Jun
284.50
0.23%
16 Jun
278.20
1.92%
Indoco Remedies Limited Graph
Indoco Remedies Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Indoco Remedies Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 326.45, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 325.90 | 329.16 | 296.24 - 362.07 |
| 332.42 | 265.93 - 398.90 | ||
| 335.68 | 234.97 - 436.38 | ||
| Bearish Scenario | 325.90 | 322.64 | 290.38 - 354.91 |
| 319.38 | 255.51 - 383.26 | ||
| 316.12 | 221.29 - 410.96 |
Overview of Indoco Remedies Limited
ISIN
INE873D01024
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
69,621
Market Cap
30,114,326,955
Last Dividend
1.5
Official Website
IPO Date
2005-01-14
DCF Diff
577.41
DCF
-286
Financial Ratios Every Investor Needs
Stock Dividend of INDOCO
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2024-09-19 | September 19, 24 | 1.5 | 1.5 | 2024-09-19 | 2024-10-26 | |
| 2023-09-18 | September 18, 23 | 2.25 | 2.25 | 2023-09-19 | 2023-10-26 | |
| 2022-09-14 | September 14, 22 | 0.75 | 0.75 | 2022-09-15 | 2022-10-22 | |
| 2021-09-17 | September 17, 21 | 1.5 | 1.5 | 2021-09-20 | 2021-10-23 | |
| 2020-09-18 | September 18, 20 | 0.3 | 0.3 | 2020-09-21 | 2020-10-24 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1,664.92 Cr | 1,006.07 Cr | 658.85 Cr | 0.3957 | 76.01 Cr | 0.00 Cr | -14.58 Cr | -73.74 Cr | -8.61 | 105.70 Cr | -0.0443 |
| 2024-03-31 | 1,788.22 Cr | 1,185.32 Cr | 602.90 Cr | 0.3372 | 97.16 Cr | 36.76 Cr | 152.44 Cr | 98.46 Cr | 10.51 | 264.71 Cr | 0.0551 |
| 2023-03-31 | 1,640.05 Cr | 521.29 Cr | 1,118.76 Cr | 0.6821 | 80.97 Cr | 264.68 Cr | 217.83 Cr | 142.25 Cr | 15.44 | 288.18 Cr | 0.0867 |
| 2022-03-31 | 1,503.74 Cr | 463.77 Cr | 1,039.97 Cr | 0.6916 | 74.64 Cr | 12.51 Cr | 255.33 Cr | 154.80 Cr | 16.80 | 324.63 Cr | 0.1029 |
| 2021-03-31 | 1,218.61 Cr | 359.64 Cr | 858.97 Cr | 0.7049 | 59.70 Cr | 16.73 Cr | 168.14 Cr | 93.05 Cr | 10.10 | 227.22 Cr | 0.0764 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 17.07 Cr | 2,429.91 Cr | 1,411.53 Cr | 1,022.0000 Cr | 993.57 Cr | 976.50 Cr | 419.35 Cr | 1,125.18 Cr | 0.00 Cr | 0.00 Cr | 11.31 Cr | 807.9900 Cr |
| 2024-03-31 | 14.86 Cr | 2,144.73 Cr | 1,034.23 Cr | 1,109.9001 Cr | 671.95 Cr | 657.10 Cr | 372.06 Cr | 979.28 Cr | 7.61 Cr | 0.00 Cr | -4.12 Cr | 612.3300 Cr |
| 2023-03-31 | 10.93 Cr | 1,658.20 Cr | 629.95 Cr | 1,028.2500 Cr | 332.85 Cr | 321.92 Cr | 325.99 Cr | 667.59 Cr | 13.06 Cr | 0.00 Cr | -2.99 Cr | 424.5100 Cr |
| 2022-03-31 | 17.47 Cr | 1,486.09 Cr | 581.45 Cr | 904.6401 Cr | 256.67 Cr | 239.20 Cr | 310.52 Cr | 584.66 Cr | 3.72 Cr | 0.00 Cr | -24.60 Cr | 424.8536 Cr |
| 2021-03-31 | 9.42 Cr | 1,315.06 Cr | 546.07 Cr | 768.9906 Cr | 266.74 Cr | 257.32 Cr | 237.85 Cr | 553.53 Cr | 54.78 Cr | -42.16 Cr | -2.08 Cr | 406.9199 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 27.8900 Cr | -344.4500 Cr | 309.3000 Cr | -328.2600 Cr | 0.0000 Cr | 17.0700 Cr | -356.1500 Cr | -73.7400 Cr | 326.8400 Cr | -13.9000 Cr | -66.2900 Cr |
| 2024-03-31 | 156.6982 Cr | -433.8300 Cr | 280.4346 Cr | -270.6049 Cr | 3.9253 Cr | 14.8557 Cr | -427.3031 Cr | 124.2707 Cr | 340.3342 Cr | -20.7059 Cr | -27.0800 Cr |
| 2023-03-31 | 178.8200 Cr | -208.1800 Cr | 22.8100 Cr | -28.4300 Cr | -6.5400 Cr | 10.9300 Cr | -207.2500 Cr | 192.7900 Cr | 72.4957 Cr | -20.7211 Cr | -15.4700 Cr |
| 2022-03-31 | 173.8287 Cr | -121.4082 Cr | -44.3720 Cr | 48.5052 Cr | 8.0485 Cr | 17.4662 Cr | -125.3235 Cr | 236.5712 Cr | -14.3053 Cr | -13.7932 Cr | -72.6647 Cr |
| 2021-03-31 | 82.2220 Cr | -66.6933 Cr | -29.8731 Cr | 5.3731 Cr | -14.3444 Cr | 9.4177 Cr | -76.8489 Cr | 131.9971 Cr | -3.0878 Cr | -2.7887 Cr | -29.5343 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 390.21 Cr | 241.11 Cr | 149.10 Cr | 0.3821 | -29.56 Cr | -40.39 Cr | -4.71 | 1.24 Cr | -0.1035 |
| 2024-12-31 | 402.45 Cr | 113.92 Cr | 288.53 Cr | 0.7169 | -16.69 Cr | -26.39 Cr | -3.08 | 13.87 Cr | -0.0656 |
| 2024-09-30 | 432.66 Cr | 258.50 Cr | 174.16 Cr | 0.4025 | 11.43 Cr | -9.57 Cr | -1.04 | 41.81 Cr | -0.0221 |
| 2024-06-30 | 431.49 Cr | 266.27 Cr | 165.22 Cr | 0.3829 | 20.25 Cr | 2.62 Cr | 0.28 | 48.80 Cr | 0.0061 |
| 2024-03-31 | 449.64 Cr | 255.41 Cr | 194.23 Cr | 0.4320 | 22.64 Cr | 22.70 Cr | 2.39 | 71.26 Cr | 0.0505 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 17.07 Cr | 0.00 Cr | 17.07 Cr | 355.72 Cr | 419.35 Cr | 1,001.34 Cr | 1,125.18 Cr | 2,429.91 Cr | 1,411.53 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 41.73 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -1,088.87 Cr |
| 2024-09-30 | 18.18 Cr | 26.32 Cr | 44.50 Cr | 383.42 Cr | 382.72 Cr | 1,034.74 Cr | 1,026.78 Cr | 2,389.83 Cr | 1,300.96 Cr |
| 2024-06-30 | -31.57 Cr | 63.14 Cr | 31.57 Cr | 0.00 Cr | 0.00 Cr | 31.57 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 24.33 Cr | 7.24 Cr | 31.57 Cr | 434.47 Cr | 353.06 Cr | 954.67 Cr | 891.09 Cr | 2,144.73 Cr | 1,034.23 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | -26.39 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | -9.57 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 2.62 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 22.70 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 16.30 Cr | 48.70 Cr | 0.00 Cr | 0.00 Cr | 48.70 Cr | 113.88 Cr | 65.18 Cr | 0.00 Cr | 48.70 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2012-05-17 | May 17, 12 | 5:1 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,672.00 | ₹4,011,596,160,000.00 | ₹1,298,300.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,835.00 | ₹1,814,480,615,000.00 | ₹224,031.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,314.20 | ₹1,121,674,419,000.00 | ₹344,196.00 |
| Mankind Pharma Limited | MANKIND | ₹2,578.30 | ₹1,064,138,561,908.00 | ₹2,780,363.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,254.70 | ₹1,044,010,449,778.00 | ₹895,308.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹979.60 | ₹985,702,908,000.00 | ₹921,030.00 |
| Lupin Limited | LUPIN | ₹1,894.70 | ₹865,339,805,200.00 | ₹1,511,045.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,124.80 | ₹653,286,089,600.00 | ₹1,058,782.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,181.10 | ₹615,508,601,100.00 | ₹15,678,334.00 |
| Alkem Laboratories Limited | ALKEM | ₹4,806.70 | ₹574,713,085,500.00 | ₹183,070.00 |
| Laurus Labs Limited | LAURUSLABS | ₹790.20 | ₹426,117,720,600.00 | ₹1,475,669.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Cohance Lifesciences Limited | COHANCE | ₹1,017.95 | ₹389,434,085,794.00 | ₹322,114.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,449.60 | ₹367,769,318,400.00 | ₹119,065.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,626.50 | ₹328,081,368,000.00 | ₹236,895.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,757.10 | ₹285,491,850,900.00 | ₹3,159,181.00 |
| Piramal Enterprises Limited | PEL | ₹1,217.50 | ₹275,980,465,000.00 | ₹2,508,249.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,608.60 | ₹251,036,507,400.00 | ₹444,444.00 |
| Eris Lifesciences Limited | ERIS | ₹1,709.80 | ₹232,869,630,600.00 | ₹106,770.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹9,241.50 | ₹231,037,500,000.00 | ₹20,847.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹976.60 | ₹191,963,425,800.00 | ₹60,016.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,165.70 | ₹185,673,861,700.00 | ₹144,076.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹961.80 | ₹172,267,998,000.00 | ₹1,353,979.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹12,301.00 | ₹157,820,599,900.00 | ₹74,663.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹2,023.30 | ₹153,794,472,610.00 | ₹35,929.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹469.00 | ₹113,800,036,000.00 | ₹331,193.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,755.50 | ₹95,537,846,700.00 | ₹23,112.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹896.75 | ₹87,693,989,575.00 | ₹154,034.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹927.20 | ₹84,036,419,664.00 | ₹291,915.00 |
| Strides Pharma Science Limited | STAR | ₹887.80 | ₹81,822,045,060.00 | ₹428,094.00 |
| FDC Limited | FDC | ₹501.35 | ₹81,624,793,500.00 | ₹72,209.00 |
| Suven Life Sciences Limited | SUVEN | ₹276.63 | ₹60,325,810,620.00 | ₹285,602.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹159.34 | ₹51,709,335,480.00 | ₹1,252,722.00 |
| Innova Captab Limited | INNOVACAP | ₹875.40 | ₹50,094,703,722.00 | ₹46,543.00 |
| Sequent Scientific Limited | SEQUENT | ₹184.32 | ₹46,136,217,600.00 | ₹343,582.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹473.60 | ₹43,225,472,000.00 | ₹158,284.00 |
| Hikal Limited | HIKAL | ₹340.50 | ₹41,983,990,500.00 | ₹164,468.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,526.20 | ₹41,780,821,800.00 | ₹17,230.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹590.85 | ₹41,599,266,930.00 | ₹17,355.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹718.30 | ₹36,431,529,530.00 | ₹55,088.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹349.05 | ₹35,002,035,900.00 | ₹50,065.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹62.67 | ₹34,340,277,180.00 | ₹1,978,828.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹664.85 | ₹32,014,522,050.00 | ₹589,436.00 |
| Indoco Remedies Limited | INDOCO | ₹326.45 | ₹30,114,326,955.00 | ₹174,646.00 |
| Alembic Limited | ALEMBICLTD | ₹117.26 | ₹30,110,257,203.00 | ₹332,328.00 |
| IOL Chemicals and Pharmaceuticals Limited | IOLCP | ₹91.18 | ₹26,763,791,860.00 | ₹1,225,212.00 |
Key Executives
Non-Executive Chairman & Whole time Director
Mr. Suresh Govind Kare
Gender: male
Year Born: 1939
Chief Technical Officer
Dr. Kavita Inamdar
Gender: Not Specified
Year Born: 1967
Chief Marketing Officer
Mr. Rajesh Usgaonker
Gender: male
Year Born:
Head of OSD
Mr. Prashant Pathak
Gender: male
Year Born:
Chief Financial Officer
Mr. Pramod Ghorpade
Gender: male
Year Born:
President of Sales & Marketing
Mr. Ajay Karajagi
Gender: male
Year Born:
Joint MD & Executive Director
Mr. Sundeep Vasant Bambolkar
Gender: male
Year Born: 1960
GM of Legal, Company Secretary & Compliance Officer
Mr. Ramanathan Hariharan
Gender: male
Year Born:
Vice President of Corporate HR
Mr. Rajan B Saawant
Gender: male
Year Born:
MD & Executive Director
Ms. Aditi Milind Panandikar
Gender: female
Year Born: 1970
FAQs about Indoco Remedies Limited
Who is the CEO of the company?
The CEO is Suresh Govind Kare.
What is the current market price of the stock?
The current price is ₹326.45.
What is the 52-week price range?
The range is ₹190-387.55.
What is the market capitalization of the company?
The market capitalization is ₹3,011.43 crores.
What is the dividend yield?
The dividend yield is 0.46%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is -39.85.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Indoco Remedies Limited (ISIN: INE873D01024) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹3,011.43 crores and an average daily volume of 69,621 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹1.5.